Stocks
GlaxoSmithKline (GSK) Operating Income US GAAP (year values) |
|||||||||
| 2022 | 2022 | 2022 | 2023 | 2023 | LTM ? | CAGR 5 years ? | |||
| Operating Income, £ | 6 433 000 000 | 6 433 000 000 | 6 433 000 000 | 6 563 000 000 | 6 745 000 000 | 3 853 000 000 | |||
| Changes by years, y/y, % | +48% | 0% | 0% | +2% | +3% | +4.2% | |||
GlaxoSmithKline. Operating Income, £
GlaxoSmithKline. Operating Income, changes, %
GlaxoSmithKline. Operating Income, sum by quarters, £
GlaxoSmithKline (GSK) Operating Income US GAAP (quarter values) |
||||||||
| 2024Q2 | 2024Q1 | 2024Q3 | 2024Q2 | 2024Q3 | LTM ? | |||
| Operating Income, £ | 1 646 000 000 | 1 490 000 000 | 189 000 000 | 1 985 000 000 | 189 000 000 | 3 853 000 000 | ||
| Changes by years, y/y, % | -23% | -28% | -90% | -7% | -90% | |||
| Changes by quarters, q/q, % | +56% | -9% | -87% | +950% | -90% | |||
